Global Automated Gram Stainer Market Overview:
Gram staining is a technique for classifying bacteria into two groups: Gram-positive and Gram-negative bacteria. Christian Gram, a Danish bacteriologist, invented the procedure. Gram staining distinguishes bacteria based on the presence or absence of peptidoglycan in the cell wall's physical and chemical characteristics. The primary stage in identifying bacteria is gram staining. When an infection is suspected, it is conducted on a clinical specimen. Manual Gram staining is inconvenient and time-consuming, and it also exposes you to harmful chemicals. Gram stainers that are automated are being utilized to reduce errors and save time. These stainers offer protection and reassurance. The market expansion of these gram staining systems is supported by several technical advantages of the automated system, such as reduced time, low reagent consumption, and standardized findings. These systems also offer a user interface that is simple to use and enables greater traceability. Furthermore, the use of automated gram staining devices is encouraged by a number of technical obstacles associated with the traditional gram staining technique. Automated methods are also more cost-effective than traditional methods since they produce less trash.
Growth Drivers
- Increasing Adoption of Automated Systems in the Laboratory Procedures
- Advantages include Reduced Time, Minimal Reagent Use and Standardized Results
Roadblocks
- Used only in High Volume Microbiology Laboratories
- High Cost of the Instrument
Opportunities
- Growing Research and Development Activities
Challenges
- Reluctance in Adopting Automation in Developing Countries
Competitive Landscape:
Some of the key players profiled in the report are Thermo Fisher Scientific (United States), Hardy Diagnostics (United States), ELITechGroup (United States), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), Lorne Laboratories Limited (United Kingdom), Lennox Framework Agreement (United States), Labema Oy (Finland) and Axon Lab AG (Switzerland). Analyst at AMA Research see United States Players to retain maximum share of Global Automated Gram Stainer market by 2026. Considering Market by Slide Capacity, the sub-segment i.e. Upto 12 Slide will boost the Automated Gram Stainer market. Considering Market by End-Use, the sub-segment i.e. Hospitals will boost the Automated Gram Stainer market.
Thermo Fisher Scientific announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research.
What Can be Explored with the Automated Gram Stainer Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Automated Gram Stainer Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Automated Gram Stainer
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Automated Gram Stainer market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Automated Gram Stainer market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Automated Gram Stainer Providers, Pharmaceutical Company, Healthcare Industry and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.